AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 14728632
Drug: Alfacalcidol (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alfacalcidol (1 microg daily for 36 weeks)
Trial: 7942728
Drug: Erythromycin ethylsuccinate
RxNorm normalized name: Erythromycin Ethylsuccinate
DrugBank: Erythromycin (DB00199)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Erythromycin ethylsuccinate elixir (400 mg/5 ml per os every 8 h for three doses)
Trial: 26185773
Drug: MOR103 1.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MOR103 1.0 mg/kg
Trial: 24534756
Drug: MOR103 1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MOR103 1.5 mg/kg
Trial: 24534756
Drug: MOR103 0.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MOR103 0.3 mg/kg
Trial: 9350924
Drug: Thallium scintigraphy
RxNorm normalized name: thallium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thallium scintigraphy after 6 months of therapy
Trial: 9350924
Drug: Exercise electrocardiography
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exercise electrocardiography after 6 months of therapy
Trial: 20431041
Drug: Octreotide LAR
RxNorm normalized name: octreotide LAR 20 MG Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Octreotide LAR depot (up to 40 mg every 28+/‐5 days)
Trial: 16169793
Drug: Heliox-driven nebulization
RxNorm normalized name: Helixate
DrugBank: Antihemophilic factor, human recombinant (DB00025)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heliox-driven nebulization of albuterol labeled with Tc-99m DTPA
Trial: 16169793
Drug: Air-driven nebulization
RxNorm normalized name: air
DrugBank: Medical air (DB09337)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Air-driven nebulization of albuterol labeled with Tc-99m DTPA
Trial: 10071149
Drug: Systemic prednisolone
RxNorm normalized name: Prednisolone
DrugBank: Prednisolone acetate (DB15566)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Systemic prednisolone treatment (group B)
Trial: 7768760
Drug: Co-amoxiclav 3.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Co-amoxiclav 3.25 g single dose
Trial: 7768760
Drug: Co-trimoxazole 960
RxNorm normalized name: CO
DrugBank: Carbon monoxide (DB11588)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Co-trimoxazole 960 mg bd for 7 days
Trial: 1983433
Drug: Cloxazolam (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cloxazolam (4 mg/day)
Trial: 1983433
Drug: Bromazepam (12
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bromazepam (12 mg/day)
Trial: 2183866
Drug: Paracetamol (4.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paracetamol (4.0 g daily)
Trial: 24011514
Drug: NCB-02 (curcumin)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NCB-02 (curcumin) enema plus oral 5-ASA
Trial: 24011514
Drug: Placebo enema
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo enema plus oral 5-ASA
Trial: 9602258
Drug: 5000 IU
RxNorm normalized name: D 5000 IU
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5000 IU rhEPO daily s.c.
Trial: 31501293
Drug: Continuation of
RxNorm normalized name: varenicline
DrugBank: Varenicline (DB01273)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Continuation of conventional HF treatment
Trial: 19464709
Drug: Pentoxifylline (PXF)
RxNorm normalized name: Pentoxifylline
DrugBank: Pentoxifylline (DB00806)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pentoxifylline (PXF) 1200 mg daily for 12 months
Trial: 16409425
Drug: 3-weekly regimen
RxNorm normalized name: Anacin Aspirin Regimen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3-weekly regimen of gemcitabine (1000 mg/qm, days 1 and 8) and paclitaxel (175 mg/qm, day 1)
Trial: 15281431
Drug: Colchicine 1
RxNorm normalized name: colchicine 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Colchicine 1 mg qd plus prednisone 10 mg qd
Trial: 10632642
Drug: Alosetron 0.5
RxNorm normalized name: alosetron 0.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alosetron 0.5 mg b.d.
Trial: 11284782
Drug: Alosetron 1.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alosetron 1.0 mg b.d.
Trial: 11284782
Drug: Alosetron 2.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alosetron 2.0 mg b.d.
Trial: 3567001
Drug: Aminophylline 670
RxNorm normalized name: Aminophylline
DrugBank: Aminophylline (DB01223)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aminophylline 670 mg (high-dose)
Trial: 3567001
Drug: Placebo (aerosol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (aerosol and infusion)
Trial: 24763840
Drug: Lignocaine (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lignocaine (10 mL of 2% lignocaine with adrenaline 1:200,000)
Trial: 24763840
Drug: Ropivacaine alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ropivacaine alone (20 mL of 0.75% ropivacaine)
Trial: 15979016
Drug: Spinal cord
RxNorm normalized name: BOS TAURUS SPINAL CORD
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spinal cord stimulation (SCS) treatment
Trial: 15790985
Drug: Salmeterol 50
RxNorm normalized name: FLUTICAS 100/SALMETEROL 50 INHL DISK 14
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Salmeterol 50 microg twice daily
Trial: 27258301
Drug: PRISE (5-6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PRISE (5-6 meals/day at 2.0 g/kg BW/day)
Trial: 17576969
Drug: Morphine 1
RxNorm normalized name: morphine 10 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine 1 mg ml(‐1)
Trial: 17576969
Drug: Morphine with
RxNorm normalized name: opium alkaloids with morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine with ketamine 1 mg ml(‐1)
Trial: 11713072
Drug: Intracameral saline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intracameral saline (0.5 ml sterile saline)
Trial: 11713072
Drug: Intracameral lidocaine
RxNorm normalized name: Lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intracameral lidocaine (0.5 ml preservative-free 2%)
Trial: 24480077
Drug: Minocycline (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Minocycline (200 mg/day)
Trial: 2885505
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg Sb/kg per day for twenty days
Trial: 2885505
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg Sb/kg per day for twenty days
Trial: 27457369
Drug: Low-level laser
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-level laser therapy (LLLT, 0.3 W, 40 s, 4 J/cm²)
Trial: 22000279
Drug: Istradefylline 10
RxNorm normalized name: istradefylline
DrugBank: Istradefylline (DB11757)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Istradefylline 10 mg/day
Trial: 18685349
Drug: Low-dose regular
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose regular opioids (especially sustained-release preparations)
Trial: 18685349
Drug: Other medications
RxNorm normalized name: Ether
DrugBank: Diethyl ether (DB13598)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Other medications (benzodiazepines, nebulised frusemide, selective serotonin reuptake inhibitors)
Trial: 11844656
Drug: Cholestin (1.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cholestin (1.2 g twice daily for 8 weeks)
Trial: 11844656
Drug: Cholestin (1.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cholestin (1.2 g twice daily for 2 weeks)
Trial: 7480980
Drug: 2.5 mg
RxNorm normalized name: biotin 2.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.5 mg rhDNase twice daily for 6 months followed by a 2-week wash-out period, then rhDNase once daily for 18 months
Trial: 1673816
Drug: Ephedrine 0.07
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ephedrine 0.07 mg kg‐1
Trial: 1673816
Drug: Etilefrine 0.03
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Etilefrine 0.03 mg kg‐1
Trial: 7125090
Drug: Soludactone: 300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Soludactone: 300 mg daily for one week, followed by aldactone orally
Trial: 22906319
Drug: Graded-exercise therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Graded-exercise therapy (GET)
Trial: 17299581
Drug: Phaseolus vulgaris
RxNorm normalized name: PHASEOLUS VULGARIS WHOLE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phaseolus vulgaris extract (445 mg) taken one tablet per day for 30 days before a carbohydrate-rich meal
Trial: 17299581
Drug: Placebo taken
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo taken one tablet per day for 30 days before a carbohydrate-rich meal
Trial: 11606175
Drug: Vitamin C
RxNorm normalized name: Vitamin C
DrugBank: Sodium ascorbate (DB14482)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin C (1250 mg) and Vitamin E (680 IU) per day
Trial: 9540877
Drug: Omeprazole/amoxicillin for
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole/amoxicillin for 2 weeks
Trial: 20557237
Drug: Azithromycin-artesunate (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Azithromycin-artesunate (30 mg/kg per day of azithromycin plus 4 mg/kg per day of artesunate) once daily for 3 days
Trial: 20557237
Drug: Control: Artemether
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control: Artemether (80 mg) plus Lumefantrine (960 mg) twice daily for 3 days
Trial: 18534016
Drug: ACZ885 10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ACZ885 10 mg/kg
Trial: 18991519
Drug: Touch treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Touch treatment (twice-weekly for 8 weeks)
Trial: 18991519
Drug: Distant therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Distant therapy (twice-weekly for 8 weeks)
Trial: 18991519
Drug: Sham control
RxNorm normalized name: BLACK BEAN ANTI HAIR LOSS SHAM POO SET KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sham control (twice-weekly for 8 weeks)
Trial: 15149781
Drug: Hexavalent DTPa‐HBV‐IPV/Hib
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hexavalent DTPa‐HBV‐IPV/Hib vaccine (Infanrix hexa)
Trial: 15149781
Drug: Separate administration
RxNorm normalized name: Atractylis separate root
DrugBank: Atractylodes lancea root (DB14693)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Separate administration of DTPa‐IPV/Hib and HBV vaccines
Trial: 11054323
Drug: Tamoxifen (oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tamoxifen (oral administration)
Trial: 1378786
Drug: Intravenous gallopamil
RxNorm normalized name: gallopamil
DrugBank: Gallopamil (DB12923)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous gallopamil 0.03 mg/kg
Trial: 29540123
Drug: Intravenous magnesium
RxNorm normalized name: immunoglobulins, intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous magnesium sulfate combined with oral nimodipine
Trial: 15292287
Drug: Additional morning
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Additional morning dose of hydrocortisone
Trial: 8164045
Drug: 1 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg/kg isotretinoin daily for 6 months
Trial: 29127533
Drug: Ontuxizumab 2
RxNorm normalized name: Ontuxizumab
DrugBank: Ontuxizumab (DB16270)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ontuxizumab 2 mg/kg
Trial: 29127533
Drug: Ontuxizumab 4
RxNorm normalized name: Ontuxizumab
DrugBank: Ontuxizumab (DB16270)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ontuxizumab 4 mg/kg
Trial: 29127533
Drug: Ontuxizumab (both
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ontuxizumab (both doses)
Trial: 12442345
Drug: Letrozole (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Letrozole (2.5 or 10 mg)
Trial: 9989712
Drug: Hirudin (0.4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hirudin (0.4 mg/kg bolus then 0.15 mg kg(‐1) h(‐1) infusion; n=5083)
Trial: 31715077
Drug: Pravastatin 40
RxNorm normalized name: pravastatin 40 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pravastatin 40 mg daily (n = 30)
Trial: 3717693
Drug: Transfusion of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transfusion of 1 unit of blood @ 5 ml/min
Trial: 3717693
Drug: Transfusion of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transfusion of 2 units of blood @ 10 ml/min
Trial: 3717693
Drug: Transfusion of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transfusion of 2 units of blood @ 5 ml/min
Trial: 3717693
Drug: Transfusion of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transfusion of 1 unit of blood @ 10 ml/min
Trial: 28918703
Drug: Other treatments
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Other treatments (MMH, PPH, PPH+sMMH)
Trial: 23231499
Drug: 800 μg
RxNorm normalized name: hyaluronidase
DrugBank: Hyaluronidase (DB14740)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: 800 μg of misoprostol orally
Trial: 21796123
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy (standard-dose candesartan 8 mg/day + controlled-release nifedipine 20 mg/day)
Trial: 21796123
Drug: Up-titrated monotherapy
RxNorm normalized name: Q-Up
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Up-titrated monotherapy (candesartan 12 mg/day)
Trial: 11025708
Drug: Bicalutamide monotherapy
RxNorm normalized name: Bicalutamide
DrugBank: Bicalutamide (DB01128)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Bicalutamide monotherapy (150 mg daily)
Trial: 11025708
Drug: Castration (orchiectomy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Castration (orchiectomy or 3.6 mg goserelin acetate every 28 days)
Trial: 9195140
Drug: Perceptual assessment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Perceptual assessment and treatment provided in a stroke unit
Trial: 8257455
Drug: gemfibrozil 1200
RxNorm normalized name: Gemfibrozil
DrugBank: Gemfibrozil (DB01241)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: gemfibrozil 1200 mg daily
Trial: 28560853
Drug: Chemotherapy (pemetrexed
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy (pemetrexed plus carboplatin)
Trial: 8469323
Drug: Felbamate (FBM)
RxNorm normalized name: Felbamate
DrugBank: Felbamate (DB00949)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Felbamate (FBM) 3,600 mg/d
Trial: 8469323
Drug: Valproate (VPA)
RxNorm normalized name: valproate
DrugBank: Valproic acid (DB00313)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Valproate (VPA) 15 mg/kg/d
Trial: 17710973
Drug: Hib‐TT mixed
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hib‐TT mixed with GSK's DTPw vaccine (Tritanrix; group 3)
Trial: 15359983
Drug: Clearance after
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clearance after cimetidine administration
Trial: 12119060
Drug: Proton Pump
RxNorm normalized name: Proton pump inhibitor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Proton Pump Inhibitors (PPIs) - omeprazole, rabeprazole, pantoprazole, or lansoprazole
Trial: 12119060
Drug: Proton Pump
RxNorm normalized name: Proton pump inhibitor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Proton Pump Inhibitors (PPIs) - newer PPIs (rabeprazole, pantoprazole, lansoprazole)
Trial: 12119060
Drug: Histamine 2-receptor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Histamine 2-receptor antagonist (ranitidine)
Trial: 1486186
Drug: Ranitidine 300
RxNorm normalized name: ranitidine 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranitidine 300 mg once daily at night
Trial: 114055
Drug: Montanoa tomentosa
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Montanoa tomentosa extracts (Zoapatle) administered orally at a daily dose of 1.0 to 1.4 gm-equivalent of dry leaves per kilogram of body weight for two days
Trial: 26180051
Drug: Fish oil
RxNorm normalized name: Fish oil
DrugBank: Fish oil (DB13961)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish oil supplementation, dosage not specified, duration not specified.
Trial: 19407947
Drug: Chinese herbal
RxNorm normalized name: GINGER 28 mg in 100 mL TOPICAL OIL [Pain Relief Honzo Seika Chinese Herbal Aroma Oil]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chinese herbal medicine (Zhao's Weitiao No. 3, 40 mL twice a day for 30 days, 6 cycles)
Trial: 19407947
Drug: Chemotherapy (OLF
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy (OLF protocol: L-OHP+LV+5-FU for 4-6 cycles)
Trial: 18162018
Drug: Ziprasidone 10-20
RxNorm normalized name: ziprasidone 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ziprasidone 10-20 mg
Trial: 18162018
Drug: Aripiprazole 9.75
RxNorm normalized name: ARIPIPRAZOLE 9.75MG/1.3ML (7.5MG/ML) INJ
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aripiprazole 9.75 mg
Trial: 15313741
Drug: 13-hour curriculum
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 13-hour curriculum in which residents practiced teaching and received feedback during 1-hour small-group sessions taught twice monthly for 6 months
Trial: 11207174
Drug: Intravenous ceftriaxone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous ceftriaxone (50 mg/kg once daily) for 10 days
Trial: 11207174
Drug: Intravenous ceftriaxone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous ceftriaxone (50 mg/kg once daily) for 3 days
Trial: 23239683
Drug: DHA-rich fish
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DHA-rich fish oil (3 g daily for 60 days)
Trial: 9062860
Drug: Saline solution
RxNorm normalized name: Unisol 4 Saline Solution
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Saline solution (negative control in experiments 2 and 3)
Trial: 8072836
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose RSV immunoglobulin (RSVIG)
Trial: 2553511
Drug: Bulk laxative
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bulk laxative (plantago rind and sorbitol)
Trial: 26931362
Drug: Proactive outreach
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Proactive outreach intervention (tailored mailings and telephone calls) with free cessation treatment (nicotine replacement therapy and intensive telephone counselling)
Trial: 31483549
Drug: Usual care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Usual care (access to a primary care physician, insurance coverage of FDA-approved smoking cessation medications, and the state's telephone quitline)
Trial: 19635962
Drug: Ceftazidime 2
RxNorm normalized name: ceftazidime 2000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ceftazidime 2 g three times a day
Trial: 19635962
Drug: Ceftazidime 6
RxNorm normalized name: ceftazidime 60 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ceftazidime 6 g per day continuously
Trial: 11380911
Drug: Additional IVIG
RxNorm normalized name: chromous chloride
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Additional IVIG treatment (1 g/kg)
Trial: 18540358
Drug: Steroid pulse
RxNorm normalized name: dulse extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Steroid pulse therapy
Trial: 8466726
Drug: Isradipine 2.5
RxNorm normalized name: isradipine 2.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isradipine 2.5 mg twice daily
Trial: 7043448
Drug: Combined clomiphene-parlodel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined clomiphene-parlodel treatment
Trial: 30381412
Drug: Patiromer 8.4
RxNorm normalized name: patiromer 8.4 GM Powder for Oral Suspension
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patiromer 8.4 g once daily without/with food for 4 weeks
Trial: 23640923
Drug: Lcn2 treatment
RxNorm normalized name: benzoyl peroxide
DrugBank: Benzoyl peroxide (DB09096)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lcn2 treatment in adipocytes
Trial: 21209304
Drug: Traditional treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Traditional treatment plus religious and spiritual assessment
Trial: 15569835
Drug: Simvastatin 20
RxNorm normalized name: simvastatin 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simvastatin 20 mg and losartan 100 mg
Trial: 15717138
Drug: Losartan 100
RxNorm normalized name: LOSARTAN 100MG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Losartan 100 mg
Trial: 11224005
Drug: Fasting glucose,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fasting glucose, fasting insulin, insulin 120 min after glucose ingestion
Trial: 9846679
Drug: GnRH-agonist down
RxNorm normalized name: Kool-Down
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GnRH-agonist down regulation for 25-40 days (Group B)
Trial: 7855098
Drug: Tea consumption
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tea consumption (8 g of instant tea) during supplementation periods in Study A
Trial: 7855098
Drug: Tea consumption
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tea consumption (8 g of instant tea) during supplementation periods in Study B
Trial: 7855098
Drug: No tea
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No tea dietary treatments in Study A
Trial: 7855098
Drug: No tea
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No tea dietary treatments in Study B
Trial: 2239725
Drug: Full-dose labetalol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Full-dose labetalol
Trial: 2239725
Drug: Half-dose labetalol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Half-dose labetalol
Trial: 2239725
Drug: Digoxin with
RxNorm normalized name: Digoxin
DrugBank: Digoxin (DB00390)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Digoxin with half-dose labetalol
Trial: 2239725
Drug: Digoxin with
RxNorm normalized name: Digoxin
DrugBank: Digoxin (DB00390)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Digoxin with full-dose labetalol
Trial: 28667579
Drug: Fish oil
RxNorm normalized name: Fish oil
DrugBank: Fish oil (DB13961)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish oil (FO) 3000 mg plus wheat germ oil (WGO) 300 mg
Trial: 26126970
Drug: Weekly paclitaxel
RxNorm normalized name: Paclitaxel
DrugBank: Paclitaxel (DB01229)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Weekly paclitaxel (WP) for 12 treatments